NeuroSense Therapeutics (NRSNW) Short Interest Ratio & Short Volume → This consistently signaled gains of 453%... 610%... and even 1036%... (From Insiders Exposed) (Ad) Free NRSNW Stock Alerts $0.12 -0.02 (-14.29%) (As of 05/17/2024 ET) Add Compare Share Share Short InterestStock AnalysisChartCompetitorsFinancialsSEC FilingsShort InterestSocial MediaStock AnalysisChartCompetitorsFinancialsSEC FilingsShort InterestSocial Media NeuroSense Therapeutics Short Interest DataCurrent Short Volume2,100 sharesPrevious Short Volume1,100 sharesChange Vs. Previous Month+90.91%Dollar Volume Sold Short$514.71Short Interest Ratio / Days to Cover0.2Last Record DateApril 30, 2024Today's Trading Volume6,049 sharesAverage Trading Volume10,116 sharesToday's Volume Vs. Average60% Short Selling NeuroSense Therapeutics ? Sign up to receive the latest short interest report for NeuroSense Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatNRSNW Short Interest Over TimeNRSNW Days to Cover Over TimeNRSNW Percentage of Float Shorted Over Time Ad Crypto 101 Media[FREE Ticket] 27 Crypto Experts Reveal Their #1 Picks Are you monitoring 13,217 cryptocurrencies everyday? If not, you could miss the ONE that can make you wealthy beyond your wildest dreams. You see, while Bitcoin and Ethereum steal all the headlines… It’s often the cryptos flying under the radar that turn small stakes into life-changing windfalls. Claim your free seat by clicking here now. NeuroSense Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/30/20242,100 shares $514.71 +90.9%N/A0.2 $0.25 4/15/20241,100 shares $341.00 -38.9%N/A0.1 $0.31 3/31/20241,800 shares $756.00 -57.1%N/A0.2 $0.42 3/15/20244,200 shares $1,217.58 +740.0%N/A0.4 $0.29 2/29/2024500 shares $140.00 +66.7%N/A0.1 $0.28 2/15/2024300 shares $60.21 +50.0%N/A0 $0.20 1/31/2024200 shares $40.00 No ChangeN/A0 $0.20 NRSNW Short Interest - Frequently Asked Questions What is NeuroSense Therapeutics' current short interest? Short interest is the volume of NeuroSense Therapeutics shares that have been sold short but have not yet been covered or closed out. As of April 30th, investors have sold 2,100 shares of NRSNW short. Learn More on NeuroSense Therapeutics' current short interest. Is NeuroSense Therapeutics' short interest increasing or decreasing? NeuroSense Therapeutics saw a increase in short interest in the month of April. As of April 30th, there was short interest totaling 2,100 shares, an increase of 90.9% from the previous total of 1,100 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.98 billion), Occidental Petroleum Co. ($3.35 billion), Charter Communications, Inc. ($3.06 billion), General Motors ($2.88 billion), Moderna, Inc. ($2.32 billion), Tractor Supply ($2.27 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.18 billion), Williams-Sonoma, Inc. ($1.95 billion), and Chesapeake Energy Co. ($1.52 billion). View all of the most shorted stocks. What does it mean to sell short NeuroSense Therapeutics stock? Short selling NRSNW is an investing strategy that aims to generate trading profit from NeuroSense Therapeutics as its price is falling. NRSNW shares are trading down $0.02 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against NeuroSense Therapeutics? A short squeeze for NeuroSense Therapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of NRSNW, which in turn drives the price of the stock up even further. How often is NeuroSense Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including NRSNW, twice per month. The most recent reporting period available is April, 30 2024. More Short Interest Resources from MarketBeat Related Companies: 180 Life Sciences Short Squeeze Alpha Tau Medical Short Squeeze Apollomics Short Squeeze Artelo Biosciences Short Squeeze BriaCell Therapeutics Short Squeeze Cardio Diagnostics Short Squeeze Carmell Short Squeeze Cassava Sciences Short Squeeze Celularity Short Squeeze Clene Short Squeeze Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:NRSNW) was last updated on 5/18/2024 by MarketBeat.com Staff From Our PartnersObama’s Forever Term [exposed]Porter & CompanyThe Overlooked Retirement Asset You Probably Don’t OwnCrypto 101 MediaCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingMost important medical advance in 100 yearsThe Oxford ClubThe Presidential candidate you should REALLY be worried aboutStansberry ResearchForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm Press[URGENT] DO NOT Touch These AI Stocks!Weiss RatingsClaim Your Complimentary Bitcoin RewardCrypto Swap Profits